What question did this study set out to answer?

March 28, 2026Oncology and TherapyOpen Access

Burden of Disease, Treatment Patterns, and Healthcare Resource Utilization in Multiple Myeloma in the Middle East and North Africa Region: A Targeted Literature Review

View Full Paper

Ask AI

Bookmark

Authors

Literature review explores treatment patterns and outcomes in multiple myeloma in the MENA region, suggesting gaps in data.

This analysis aims to explore the incidence, treatment patterns, and healthcare resource utilization of multiple myeloma in the MENA region.
Literature search conducted using PubMed and Embase from January 2015 to May 2025.
Identified 94 articles reporting outcomes of interest in patients with multiple myeloma.
Focused on data from Egypt, Saudi Arabia, Turkey, and the United Arab Emirates.
Most included studies were retrospective observational with a significant number from Turkey.
Age-standardized incidence rate in MENA was 1.49 per 100,000 in 2019.
Median age at diagnosis was lower in MENA (43–70 years) than global reports (70 years).
Bortezomib was used in nearly half of the cases, with lenalidomide and daratumumab also common.
Overall response rates ranged from 35% to 90.2%, with survival outcomes showing considerable variation.

Beksaç et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark